Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03623165 · ClinicalTrials.gov registry record
PRODIGY Registry in NYHA Class III Heart Failure Patients
A clinical trial, sponsored by Endotronix.
- Terminated
- Registry status
- 7
- Enrollment target
NCT03623165: Clinical Trial study, sponsored by Endotronix.
NCT03623165 is a clinical trial that was terminated before completion, run by Endotronix. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03623165 was terminated before completion, sponsored by Endotronix.
- TERMINATED
- Registry status
- 7 participants
- Enrollment target
Study Summary
This is an observational, prospective, single arm, multi-center registry to evaluate the Cordella™ Heart Failure System (CHFS) in up to 250 NYHA Class III HF patients .
Primary Outcome
The KCCQ is a 23-item, self-administered instrument that quantifies physical function, symptoms (frequency, severity and recent change), social function, self-efficacy and knowledge, and quality of life. An overall summary score can be derived from the physical function, symptom (frequency and severity), social function and quality of life domains. For each domain, the validity, reproducibility, responsiveness and interpretability have been independently established. Scores are transformed to a
Interventions
- DEVICE Cordella™ Heart Failure System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2019-08-15 |
Why NCT03623165 stopped before completion
NCT03623165 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Cordella™ Heart Failure System is the first listed.
NCT03623165 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03623165 about?
NCT03623165 is a clinical study titled "PRODIGY Registry in NYHA Class III Heart Failure Patients". This is an observational, prospective, single arm, multi-center registry to evaluate the Cordella™ Heart Failure System (CHFS) in up to 250 NYHA Class III HF patients .
What is the current status of trial NCT03623165?
This trial is currently terminated. The enrollment target is 7 participants. The study started on 2018-08-01. Estimated completion is 2019-08-15.
What interventions are being tested in trial NCT03623165?
The interventions under investigation include: Cordella™ Heart Failure System (DEVICE).
Who is sponsoring clinical trial NCT03623165?
This trial is sponsored by Endotronix, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI